IVD News and Research

RSS
IDT’s fully licensed MGB Eclipse qPCR probes available for online ordering

IDT’s fully licensed MGB Eclipse qPCR probes available for online ordering

Roche unveils series of new diagnostic technologies at EuroMedLab

Roche unveils series of new diagnostic technologies at EuroMedLab

Hitachi High-Technologies, QIAGEN form new strategic partnership to advance molecular testing

Hitachi High-Technologies, QIAGEN form new strategic partnership to advance molecular testing

VENTANA ALK (D5F3) CDx Assay receives FDA approval

VENTANA ALK (D5F3) CDx Assay receives FDA approval

Bio-Techne to acquire 100% ownership of Cliniqa

Bio-Techne to acquire 100% ownership of Cliniqa

Ventana, Halozyme partner to develop companion diagnostic assay for cancer treatment

Ventana, Halozyme partner to develop companion diagnostic assay for cancer treatment

First new treatment authorised in a decade for advanced cervical cancer patients in the UK

First new treatment authorised in a decade for advanced cervical cancer patients in the UK

Cepheid, FIND announce receipt of CE-IVD status for Xpert HIV-1 Qual test

Cepheid, FIND announce receipt of CE-IVD status for Xpert HIV-1 Qual test

Mobidiag announces CE-IVD marking and launching of Amplidiag C. difficile+027 test

Mobidiag announces CE-IVD marking and launching of Amplidiag C. difficile+027 test

Frost & Sullivan forecasts growth of global healthcare market

Frost & Sullivan forecasts growth of global healthcare market

Healthcare reform changes boost glucose testing in states with healthcare exchanges

Healthcare reform changes boost glucose testing in states with healthcare exchanges

MTI Expo 2015 to focus on engineering requirements in the medical technology sector

MTI Expo 2015 to focus on engineering requirements in the medical technology sector

Kalorama Information: Budding market for digital PCR reached 175 million in 2014

Kalorama Information: Budding market for digital PCR reached 175 million in 2014

Tissue and cell diagnostics market reaches $7.7 billion in 2014

Tissue and cell diagnostics market reaches $7.7 billion in 2014

Biocartis to develop Rapid Ebola Virus Triage Test

Biocartis to develop Rapid Ebola Virus Triage Test

Sophia Genetics obtains CE-IVD marking for BRCA1/2 testing solution

Sophia Genetics obtains CE-IVD marking for BRCA1/2 testing solution

QIAGEN's circulating tumor DNA test CE-IVD marked to assess genomic mutation NSCLC patients

QIAGEN's circulating tumor DNA test CE-IVD marked to assess genomic mutation NSCLC patients

DiaCarta raises $8 million in Series A financing from BVCF

DiaCarta raises $8 million in Series A financing from BVCF

Proteomics market expected to experience continual growth

Proteomics market expected to experience continual growth

FDA provides Emergency Use Authorization for Roche's LightMix Ebola Zaire rRT-PCR Test

FDA provides Emergency Use Authorization for Roche's LightMix Ebola Zaire rRT-PCR Test